share_log

Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $11

Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $11

Chardan Capital維持對Coya Therapeutics的買入,將目標股價上調至11美元
Benzinga ·  2023/06/08 05:20

Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and raises the price target from $9 to $11.

Chardan Capital分析師Keay Nakae維持Coya Therapeutics(納斯達克股票代碼:COYA)的買入,並將目標股價從9美元上調至11美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論